CloudMD Announces Divestment of Primary Care Clinics and Cloud Practice to WELL Health
VANCOUVER, British Columbia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
VANCOUVER, British Columbia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase...
US Insurance Award Recognizes Their Innovative Solution for Managing Return-to-Work and Temporary Total DisabilityFORT WORTH, Texas, Oct. 11, 2022 (GLOBE...
- Company to showcase products including recently FDA cleared SiLO TFXTM at booth #4604 – CARLSBAD, Calif., Oct. 11, 2022...
Eight Posters Highlighting Pre-Clinical Programs and Leading Gene Therapy Manufacturing and Administration CapabilitiesLEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 11,...
Collaboration Streamlines Clinical Trial Tokenization, Further Empowers Medical Affairs, Market Access, HEOR and Commercial Analytics for ClientsMORRISVILLE, N.C., Oct. 11, 2022...
NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis Data...
Arecor Therapeutics plc(“Arecor”, the “Company” or the “Group”) HEADLINE RESULTS FROM PHASE I CLINICAL TRIAL OF ULTRA-RAPID ACTING INSULIN CANDIDATE...
Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7%...
Experienced nephrologist brings extensive clinical leadership and industry expertise to drive transformational approaches to treating kidney diseasesCAMBRIDGE, Mass., Oct. 11,...